Data as of · ABBV trades at $286.44 (-0.10% today) · Health Care sector.
Forecast: StoQuant's ML model gives ABBVIE INC (ABBV) a score of 0.44 for beating the S&P 500 over the forecast period — leans underperform. The score is a model output, not a calibrated probability; the walk-forward track record is published at /proof and the model methodology at /methodology. Wall Street's consensus 12-month price target is $311.31 from 100 analyst targets.
ML Forecast
44%
Model score vs the S&P 500 over the forecast period — leans underperform
Q-Score
91/100
Grade A — "Strong Buy" composite of 140+ signals
Analyst Target
$311.31
100 targets · $306.67–$317.50 · implied +8.7%
Next Earnings
2026-10-30
in 2 days — expect volatility
Unlock ABBV's forecast, fair value, insider detail & signals. Sign up free →
The ML model scores ABBV on 52 live features, trained on 5,328 labeled outcomes and walk-forward validated. Biggest drivers of the current model reading (score 0.44, leans underperform):
Across 100 price targets published in the last 90 days (latest 2026-10-28), the consensus for ABBVIE INC is $311.31 — spanning $306.67 on the low end to $317.50 on the high end.
StoQuant publishes its full walk-forward accuracy, updated daily. Current hit rates across all scored signals:
| Signal | Window | Hit rate | Avg return | Observations |
|---|---|---|---|---|
| Fundamental Undervalue | 7d | 50.6% | +0.45% | 9,620 |
| Volume Spike | 7d | 48.8% | +0.19% | 6,449 |
| Sector Momentum | 7d | 48.6% | +0.03% | 16,414 |
| Bollinger Squeeze | 7d | 46.8% | -0.17% | 8,985 |
See the full live track record → · How the model works
⚠ ABBVIE INC reports earnings on 2026-10-30 — expect elevated volatility and a forecast refresh right after the report.
Similar stocks to ABBV for comparison and diversification research:
Compare ABBV vs AZN head-to-head →
AAPL MSFT NVDA GOOGL GOOG AMZN META TSLA AVGO LLY JPM V WMT XOM UNH MA COST ORCL HD NFLX
Discover other stocks and tools:
StoQuant's ML model gives ABBVIE INC (ABBV) a score of 0.44 for beating the S&P 500 over the forecast period — leans underperform. The score is a model output, not a calibrated probability; the walk-forward track record is published at /proof and the model methodology at /methodology. Wall Street's consensus 12-month price target is $311.31 from 100 analyst targets.
StoQuant's Q-Score rates ABBV 91/100 (grade A, "Strong Buy") and the ML model score is 0.44 (leans underperform). StoQuant publishes its full walk-forward track record at /proof — always check a forecaster's accuracy before acting.
The consensus analyst price target for ABBVIE INC is $311.31, with a range of $306.67 to $317.50 across 100 recent analyst targets — an implied +8.7% move from the current price of $286.44.
Across StoQuant's walk-forward validated signal history, the fundamental undervalue signal hit its 7-day target in 50.6% of 9,620 observations (avg return +0.45%). Full methodology and live accuracy at /proof.
ABBVIE INC is scheduled to report earnings on 2026-10-30. Expect elevated forecast volatility around the report.
MSFT · AAPL · NVDA · GOOGL · META · TSLA · AMD · INTC · QCOM · AVGO
BRK.B · JPM · V · MA · WMT · PG · JNJ · XOM · UNH · HD
COST · MCD · NFLX · DIS · PFE · ABBV · TMO · CRM · ADBE
BAC · WFC · GS · MS · CVX · COP · UBER · AMAT · MU
Unlock ABBV's forecast, fair value, insider detail & signals.
ML forecasts, Q-Scores, insider clusters, and catalysts across 4,000+ tickers. Free to start.
Sign up free → Open the free screenerRegister founding interest — Pro $29/mo or Power $79/mo
Paid plans aren’t for sale yet. Leave your email to lock founding pricing (Pro $29, Power $79); we’ll reach out personally.
Track record · Methodology · All forecasts · ABBV deep dive
Forecasts are probabilistic model outputs, not investment advice. Past accuracy does not guarantee future results.
Free StoQuant digest by email. No account needed. See today's research picks.